UMANG SHAH: Open Payments
NPI 1942732086 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 9 payments from 7 companies in 2025. Trend: 2023 $52 · 2024 $80 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| Alkermes, Inc. | 2 | $52 |
| ABBVIE INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: HETLIOZ, ARISTADA, LYBALVI, VRAYLAR, COBENFY, Xelstrym, SPRAVATO, Qelbree.
Industry payments across KS — which companies pay providers there.
